Melbourne Stem Cell Centre, located in Box Hill, Melbourne is committed to the ethical development and research into conservative treatments for osteoarthritis. . MSCC follows the National Health and Medical Research Councils guidelines for regenerative therapies. Working closely with partners Magellan Stem Cells, MSCC is an industry leader in the area of stem cell research for the treatment of arthritis and other joint disorders. MSCC is a founding member of the Australian Consortium of Autologous Cell Users and abides by its industry code of ethics.

MSCC Team Image For Web.jpg

Meet our Sports Medicine Doctors...

0401STEM CELLS .jpg

Dr Julien Freitag

Head of Clinical Research

Associate Professor/Sports Medicine Physician

Assoc. Prof. Julien Freitag is an experienced musculoskeletal specialist and is a fellow of the Australasian College of Sport and Exercise Physicians.

His practice is focused on the active management of musculoskeletal conditions including osteoarthritis and tendinopathy.

Assoc. Prof. Freitag is an authority in the area of clinical regenerative musuloskeletal medicine including techniques such as Platelet-rich Plasma (PRP) and Mesenchymal Stem Cell (MSC) therapy. He has published numerous international articles in the area of regenerative medicine and is a frequent contributor and invited speak to local and international conferences. Assoc. Prof. Freitag is the Principle Clinical Investigator in a number of world leading research projects assessing the benefits of stem cell therapy in arthritis.

MSCC our Lab.jpg

Our Associates 


Magellan Stem Cells

Magellan Stem Cells operates a specialised stem cell laboratory in Melbourne that provides stem cell services to doctors throughout Australia. Magellan Stem Cells is seeking to work with doctors who are treating patients who have conditions that can benefit from the provision of stem cell therapies.

Melbourne Stem Cell Centre Goals for web.jpg

Our Goals


MSCC is committed to the further development of stem cell based therapies for osteoarthritis.  We have completed recruitment of a world first randomised controlled trial on the use of stem cells in arthritis with results expected to be published in 2018.   MSCC has also partnered with leading medical specialists and has commenced studies in the area of lower back pain. 

Further to the importance of research in appropriate stem cell development, MSCC has partnered with Charles Sturt University in its ongoing research program.